BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
December 27, 2012 at 18:55 PM EST
Marvell has options as it faces $1 bln patent verdict
NEW YORK, Dec 27 (Reuters) - As Marvell Technology Group Ltd embarks on a legal process to void a $1.17 billion damages verdict in a patent dispute with Carnegie Mellon University, it has some reasons to be optimistic.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here